| 000 | 01684 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517131233.0 | ||
| 264 | 0 | _c20170405 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1678-9946 | ||
| 024 | 7 |
_a10.1590/S1678-9946201658088 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRamzy, Iman | |
| 245 | 0 | 0 |
_aGENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. _h[electronic resource] |
| 260 |
_bRevista do Instituto de Medicina Tropical de Sao Paulo _cDec 2016 |
||
| 300 |
_a88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aClarithromycin _xpharmacology |
| 650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 | _aEgypt |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 |
_aHelicobacter Infections _xmicrobiology |
| 650 | 0 | 4 |
_aHelicobacter pylori _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetronidazole _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aRNA, Ribosomal, 16S |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aElgarem, Hassan | |
| 700 | 1 | _aHamza, Iman | |
| 700 | 1 | _aGhaith, Doaa | |
| 700 | 1 | _aElbaz, Tamer | |
| 700 | 1 | _aElhosary, Waleed | |
| 700 | 1 | _aMostafa, Gehan | |
| 700 | 1 | _aElzahry, Mohammad A Mohey Eldin | |
| 773 | 0 |
_tRevista do Instituto de Medicina Tropical de Sao Paulo _gvol. 58 _gp. 88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1590/S1678-9946201658088 _zAvailable from publisher's website |
| 999 |
_c26703929 _d26703929 |
||